| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antimicrobial De-Escalation in the ICU: From Recommendations to Level of Evidence
|
Lakbar, Ines
|
|
|
37 |
7 |
p. 3083-3096
|
artikel
|
| 2 |
A Review of Two Regulatory Approved Anti-CD19 CAR T-Cell Therapies in Diffuse Large B-Cell Lymphoma: Why Are Indirect Treatment Comparisons Not Feasible?
|
Zhang, Jie
|
|
|
37 |
7 |
p. 3040-3058
|
artikel
|
| 3 |
Best Practice Approach to Successful Conversion of Fosaprepitant to Aprepitant IV in a Large Multisite Community Oncology Infusion Center: A Retrospective Analysis
|
Burns, Derek
|
|
|
37 |
7 |
p. 3265-3277
|
artikel
|
| 4 |
Correction to: Dual Antiplatelet Therapy Duration in Medically Managed Acute Coronary Syndrome Patients: Sub-Analysis of the OPT-CAD Study
|
Ma, Sicong
|
|
|
37 |
7 |
p. 3162
|
artikel
|
| 5 |
Correction to: Panel Discussion: Some Aspects of the Management of Patients with X-Linked Hypophosphataemic Rickets
|
Torregrosa, José-Vicente
|
|
|
37 |
7 |
p. 3432
|
artikel
|
| 6 |
Correction to: Real-World Treatment Patterns, Adverse Events, Resource Use, and Costs Among Commercially Insured, Younger Patients with Chronic Lymphocytic Leukemia in the USA: A Retrospective Cohort Study
|
Kabadi, Shaum M.
|
|
|
37 |
7 |
p. 3149
|
artikel
|
| 7 |
Cost-Effectiveness of Coronary and Peripheral Artery Disease Antithrombotic Treatments in Finland
|
Soini, Erkki
|
|
|
37 |
7 |
p. 3348-3369
|
artikel
|
| 8 |
Denosumab Versus Zoledronic Acid in Bone Disease Treatment of Newly Diagnosed Multiple Myeloma: An International, Double-Blind, Randomized Controlled Phase 3 Study—Asian Subgroup Analysis
|
Huang, Shang-Yi
|
|
|
37 |
7 |
p. 3404-3416
|
artikel
|
| 9 |
Development and Validation of a Nomogram-Based Prognostic Evaluation Model for Sarcomatoid Hepatocellular Carcinoma
|
Ge, Dazhuang
|
|
|
37 |
7 |
p. 3185-3205
|
artikel
|
| 10 |
Diagnosis and Management of Hypothyroidism in Gulf Cooperation Council (GCC) Countries
|
Alzahrani, Ali S.
|
|
|
37 |
7 |
p. 3097-3111
|
artikel
|
| 11 |
Dual Antiplatelet Therapy Duration in Medically Managed Acute Coronary Syndrome Patients: Sub-Analysis of the OPT-CAD Study
|
Ma, Sicong
|
|
|
37 |
7 |
p. 3150-3161
|
artikel
|
| 12 |
Dysfunctional Coagulation in COVID-19: From Cell to Bedside
|
Wang, Jie
|
|
|
37 |
7 |
p. 3033-3039
|
artikel
|
| 13 |
Etrolizumab for the Treatment of Ulcerative Colitis and Crohn’s Disease: An Overview of the Phase 3 Clinical Program
|
Sandborn, William J.
|
|
|
37 |
7 |
p. 3417-3431
|
artikel
|
| 14 |
Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA
|
Olson, Amy L.
|
|
|
37 |
7 |
p. 3292-3298
|
artikel
|
| 15 |
Incidence of Pericardial Effusion in Patients with Advanced Non-Small Cell Lung Cancer Receiving Immunotherapy
|
Canale, Maria Laura
|
|
|
37 |
7 |
p. 3178-3184
|
artikel
|
| 16 |
Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Mini-Tabs Plus Ribavirin for Children Aged 3–11 Years with Hepatitis C Genotype 1a
|
Rosenthal, Philip
|
|
|
37 |
7 |
p. 3299-3310
|
artikel
|
| 17 |
Papillary Thyroid Cancer—Aggressive Variants and Impact on Management: A Narrative Review
|
Coca-Pelaz, Andrés
|
|
|
37 |
7 |
p. 3112-3128
|
artikel
|
| 18 |
Persistence of Inflammation After Uncomplicated Cataract Surgery: A 6-Month Laser Flare Photometry Analysis
|
De Maria, Michele
|
|
|
37 |
7 |
p. 3223-3233
|
artikel
|
| 19 |
PF-06881894, a Proposed Biosimilar to Pegfilgrastim, Versus US-Licensed and EU-Approved Pegfilgrastim Reference Products (Neulasta®): Pharmacodynamics, Pharmacokinetics, Immunogenicity, and Safety of Single or Multiple Subcutaneous Doses in Healthy Volunteers
|
Moosavi, Shahrzad
|
|
|
37 |
7 |
p. 3370-3391
|
artikel
|
| 20 |
Pharmacokinetics and Dialyzability of a Single Oral Dose of Amenamevir, an Anti-Herpes Drug, in Hemodialysis Patients
|
Tsuruoka, Shuichi
|
|
|
37 |
7 |
p. 3234-3245
|
artikel
|
| 21 |
Prevalence and Management Challenges in Central Post-Stroke Neuropathic Pain: A Systematic Review and Meta-analysis
|
Liampas, Andreas
|
|
|
37 |
7 |
p. 3278-3291
|
artikel
|
| 22 |
Real-World Treatment Patterns, Adverse Events, Resource Use, and Costs Among Commercially Insured, Younger Patients with Chronic Lymphocytic Leukemia in the USA: A Retrospective Cohort Study
|
Kabadi, Shaum M.
|
|
|
37 |
7 |
p. 3129-3148
|
artikel
|
| 23 |
Real-World Treatment Patterns and Outcomes in Patients Receiving Second-Line Therapy for Advanced/Metastatic Esophageal Squamous Cell Carcinoma
|
Abraham, Pranav
|
|
|
37 |
7 |
p. 3392-3403
|
artikel
|
| 24 |
The Burden of Progressive Fibrosing Interstitial Lung Disease: A DELPHI Approach
|
Wuyts, Wim A.
|
|
|
37 |
7 |
p. 3246-3264
|
artikel
|
| 25 |
The Promise for Histone Methyltransferase Inhibitors for Epigenetic Therapy in Clinical Oncology: A Narrative Review
|
Rugo, Hope S.
|
|
|
37 |
7 |
p. 3059-3082
|
artikel
|
| 26 |
Treatment of Oculoplastic and Ocular Surface Disease in Eyes Implanted with a Type I Boston Keratoprosthesis in Southern China: A Retrospective Study
|
Zhang, Yuying
|
|
|
37 |
7 |
p. 3206-3222
|
artikel
|
| 27 |
Treatment Patterns Among Patients with Multiple Sclerosis Initiating Second-Line Disease-Modifying Therapy
|
Bowen, James
|
|
|
37 |
7 |
p. 3163-3177
|
artikel
|
| 28 |
Treatment Persistence Between Long-Acting Injectable Versus Orally Administered Aripiprazole Among Patients with Schizophrenia in a Real-World Clinical Setting in Japan
|
Iwata, Nakao
|
|
|
37 |
7 |
p. 3324-3336
|
artikel
|
| 29 |
Treatment Sequencing in Patients with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer in Japan: A Real-World Observational Study
|
Goto, Yasushi
|
|
|
37 |
7 |
p. 3311-3323
|
artikel
|
| 30 |
Troponin Levels Relate to CRP Concentrations in Patients With NAFLD on Maintenance Haemodialysis: A Retrospective Study
|
Capone, Domenico
|
|
|
37 |
7 |
p. 3337-3347
|
artikel
|
Tijdschrift beschrijving